Literature DB >> 17084579

Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer.

C Lanng1, J Hoffmann, H Galatius, U Engel.   

Abstract

AIMS: Clinically palpable lymph nodes (LNs) are regarded as a contraindication for performing the sentinel node (SN) procedure. Many studies have shown, however, that clinical assessment of axillary LNs is inaccurate. This study evaluated the reliability of clinical axillary LN assessment by experts and assessed whether inaccuracy can be related to LN size.
METHODS: Three hundred and one consecutive breast cancer patients undergoing either axillary dissection or SN were studied prospectively.
RESULTS: The risk of having metastasis to the LN was 40.4% if the preoperative clinical assessment was "non-palpable LN", 61.5% if the assessment was "palpable but benign LN" and 84.4% if it was "suspicious LN". There were no clinically significant differences in mean size either when the LN was palpable versus non-palpable, or when the LN had metastasis or not.
CONCLUSIONS: The clinical assessment of axillary LNs as a criterion for offering the SN procedure is of little value.

Entities:  

Mesh:

Year:  2006        PMID: 17084579     DOI: 10.1016/j.ejso.2006.09.032

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  17 in total

1.  The value of axillary ultrasound with fine needle aspiration as a pre-operative staging procedure in breast cancer: Northern Irish experience.

Authors:  P Davey; M Stokes; R Kennedy; S Kirk; J Newell; C Majury; J McKillen
Journal:  Ir J Med Sci       Date:  2011-01-29       Impact factor: 1.568

2.  Tumor size of breast invasive ductal cancer measured with contrast-enhanced ultrasound predicts regional lymph node metastasis and N stage.

Authors:  Zhiyuan Wang; Qichang Zhou; Jun Liu; Shichu Tang; Xia Liang; Zhengyu Zhou; Ying He; Hui Peng; Yuanming Xiao
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Clinical assessment of axillary lymph nodes and tumor size in breast cancer compared with histopathological examination: a population-based analysis of 2,537 women.

Authors:  Shabaz Majid; Ingrid Tengrup; Jonas Manjer
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

Review 4.  Current status of sentinel lymph-node biopsy in patients with breast cancer.

Authors:  Gang Cheng; Stephanie Kurita; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-11       Impact factor: 9.236

5.  [Sentinel lymph node biopsy in breast cancer].

Authors:  Gero Luschin
Journal:  Wien Med Wochenschr       Date:  2010-10-12

6.  Accuracy of individual descriptors and grading of nodal involvement by axillary ultrasound in patients of breast cancer.

Authors:  Navneet Kaur; Pradeep Sharma; Akhil Garg; Anupama Tandon
Journal:  Int J Breast Cancer       Date:  2013-12-19

7.  Feasibility of sentinel lymph node biopsy in breast cancer patients clinically suspected of axillary lymph node metastasis on preoperative imaging.

Authors:  Hee Yong Kwak; Byung Joo Chae; Ja Seong Bae; Eun Jin Kim; Eun Young Chang; Sang Hoon Kim; Sang Seol Jung; Byung Joo Song
Journal:  World J Surg Oncol       Date:  2013-05-21       Impact factor: 2.754

8.  Can We Avoid Axillary Lymph Node Dissection (ALND) in Patients with 1-2 Positive Sentinel/Low Axillary Lymph Nodes (SLN/LAS+) in the Indian Setting?

Authors:  A Reddy; Nita S Nair; Smruti Mokal; V Parmar; T Shet; R Pathak; G Chitkara; P Thakkar; S Joshi; R A Badwe
Journal:  Indian J Surg Oncol       Date:  2021-03-02

9.  Intraoperative frozen section assessment of sentinel lymph nodes in the operative management of women with symptomatic breast cancer.

Authors:  Rohanna Ali; Ann M Hanly; Peter Naughton; Constantino F Castineira; Rob Landers; Ronan A Cahill; R Gordon Watson
Journal:  World J Surg Oncol       Date:  2008-06-26       Impact factor: 2.754

10.  Diagnostic value of preoperative axillary lymph node ultrasound assessment in patients with breast cancer qualified for sentinel lymph node biopsy.

Authors:  Tomasz Nowikiewicz; Adam Nowak; Magdalena Wiśniewska; Michał Wiśniewski; Wojciech Zegarski
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-06-15       Impact factor: 1.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.